Cambridge Investment Research Advisors, Inc.
Position in NMTC — NEUROONE MEDICAL TECHNOLOGIES Corp
CIK 1419186
FAIRFIELD, IA
Position in NMTC
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$86,636
-$46,231 QoQ
Shares Held
28,499
-83.3% QoQ
Ownership
0.327%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 4 holders
Holding Since
Jun 2024
7 quarters on record
Common Shares in NMTC Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $94,268,569 across 26 Medical Devices names. NMTC ranks #24 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
299,079 | $27,138,428 | |
| 2 | SYK |
Stryker Corp
|
73,172 | $23,037,472 | |
| 3 | MDT |
Medtronic plc
|
241,070 | $18,858,906 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
82,290 | $5,267,382 | |
| 5 | EW |
Edwards Lifesciences Corp
|
45,749 | $4,138,454 | |
| 6 | DXCM |
Dexcom Inc
|
45,009 | $3,031,356 | |
| 7 | BSX |
Boston Scientific Corp
|
51,066 | $2,179,496 | |
| 8 | STE |
STERIS plc
|
7,965 | $1,677,190 |
All Filings in NMTC
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,636 | 28,499 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $132,867 | 171,000 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $129,618 | 171,000 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $107,569 | 121,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $54,918 | 81,000 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $68,850 | 81,000 | Shares | Sole | 2025-04-22 | |
| 2024-06-30 | $8,320 | 10,400 | Shares | Sole | 2024-07-26 | |
| No filing history on record for this holder in this stock. | ||||||